Home/Filings/4/0001193805-20-001112
4//SEC Filing

O'Connor Rita M 4

Accession 0001193805-20-001112

CIK 0001497504other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 8:49 AM ET

Size

7.0 KB

Accession

0001193805-20-001112

Insider Transaction Report

Form 4
Period: 2020-09-01
O'Connor Rita M
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-09-01$3.74/sh+4,500$16,83710,850 total
  • Purchase

    Common Stock

    2020-09-02$3.83/sh+2,120$8,12712,970 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.65 to $3.85, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.

Issuer

PLx Pharma Inc.

CIK 0001497504

Entity typeother

Related Parties

1
  • filerCIK 0001389177

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 8:49 AM ET
Size
7.0 KB